McKesson Medical-Surgical has stopped shipping the products specified in FDA’s Warning Letters issued on March 18, 2024.  McKesson Medical-Surgical is engaging with Cardinal Health regarding the Warning Letter it received on April 24, 2024 to determine if any additional action is required.

We continue to work with our suppliers to help ensure that all necessary actions are taken with respect to the Warning Letters and subsequent product holds and recalls initiated by certain suppliers. This includes both privately labeled McKesson Brands and national brand products. We are also continuing to transition away from plastic syringes manufactured by the China-based suppliers noted in FDA’s updated Safety Communication.

McKesson Medical-Surgical customers can view alternate products in your SupplyManager account or can contact us at MMSSyringe@McKesson.com for further assistance.

McKesson Brand Products Identified in March 18, 2024 Warning Letters

 

Brand

Item Number

Product Description


McKesson Brands

1150041

Syringe/NDL, Safety Prevent HT3CC 25Gx1” (50/BX 8BX/CS)


McKesson Brands

1150042

Syringe/NDL, Safety Prevent HT3CC 25GX5/8” (50/BX 8BX/CS)


McKesson Brands

869662

Syringe/NDL, LL 60CC (25/BX4BX/CS)

 

The specific Warnings Letters identify the national brand products that have been affected.

McKesson Medical-Surgical is engaging with Cardinal Health regarding the Warning Letter it received on April 24, 2024 to determine if any additional action is required.

Additional information can be found in the “Supplier Actions” tab on this site.

top